Immunity to polyomavirus infection: the polyomavirus-mouse model.
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzymeNK cells and gammadelta T cells mediate resistance to polyomavirus-induced tumors.Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based TherapyB cell TLRs and induction of immunoglobulin class-switch DNA recombination.A cornucopia of human polyomaviruses.NK cells and virus-related cancers.Gamma interferon controls mouse polyomavirus infection in vivoPolymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus.Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.Long-lasting T cell-independent IgG responses require MyD88-mediated pathways and are maintained by high levels of virus persistence.Review on the relationship between human polyomaviruses-associated tumors and host immune system.Immunotherapy for polyomaviruses: opportunities and challenges.Inflammatory cytokine-mediated evasion of virus-induced tumors from NK cell control.Exploitation of stable nanostructures based on the mouse polyomavirus for development of a recombinant vaccine against porcine circovirus 2.
P2860
Q24624348-EF2EC4D0-2045-4E4B-A2F0-509EA84350E5Q26826085-F2F5C090-2EF2-4D7B-B773-BE0302500857Q27004277-3A1DD06E-6075-449C-BDF6-89A570F7FB43Q33594446-24422F3D-65FF-4B77-8B21-79289244DD0BQ33636211-B2AF5CB1-5E32-43AC-B6FE-66707D60C2ACQ33893517-046B897A-BCE1-481B-93F2-657340BF6252Q34332024-9AEE339E-3E67-4297-A5E2-2ACD6B106FB0Q34337237-AFFCF203-7078-498E-A2EF-1645B93FBE70Q35382791-E6A692CC-9803-45E5-B7A6-598250A9CC3BQ36363286-1A61BE61-DAC0-478E-BDE6-FB10F58810A9Q36626711-7A23E398-3383-4697-BECF-AC6552C6F643Q37482500-2259DE45-1B9A-4A91-ABE9-5DB44648A865Q38001435-73D5529E-5D39-4374-97FF-FA9684F83A8CQ38025665-46F435B5-1775-46DF-88B5-E3E1294D61C1Q39138817-145E2A26-B7BF-4F2D-A66A-E7D024AA9C80Q41702578-4F3292CF-C7BB-4C03-AAB8-8D63A3F942F7
P2860
Immunity to polyomavirus infection: the polyomavirus-mouse model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@en
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@nl
type
label
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@en
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@nl
prefLabel
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@en
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@nl
P2093
P2860
P1476
Immunity to polyomavirus infection: the polyomavirus-mouse model.
@en
P2093
Aron E Lukacher
Eva Szomolanyi-Tsuda
Phillip A Swanson
P2860
P304
P356
10.1016/J.SEMCANCER.2009.02.003
P577
2009-02-14T00:00:00Z